Found offers a genuinely broad "whole person" program — coaching, community, and multiple medication tiers — but its pricing structure across compounded, branded, and generic plans can be confusing to compare at a glance.
If you want structured behavioral coaching alongside medication, Found's model has real value. If you want a simpler, flat price focused specifically on GLP-1 treatment, Luma Health's semaglutide ($197/month) and tirzepatide ($297/month) are more straightforward to compare.
Found was built around the idea that lasting weight loss requires more than a prescription — it pairs GLP-1 medication with health coaching, community support, and habit-tracking tools. That "whole person" philosophy differentiates it from more medication-first platforms, though it also means Found's plan structure has more moving parts to evaluate.
How Found's Program Works
Found offers several distinct plan families: a compounded GLP-1 plan (which bundles the compounded medication cost into the cycle price), a branded GLP-1 plan (which bills brand-name medication separately, through insurance or cash pay), and a non-GLP-1 generics plan for other appetite or metabolic medications. Membership costs have been reported in a range depending on the specific tier and whether you're self-pay or using insurance, with compounded plans commonly starting somewhere in the $99-$199/month range and branded plans priced differently based on insurance status.
Where Pricing Gets Confusing
Because Found segments its offering into multiple plan families with different billing structures, comparing your actual total cost requires understanding which specific plan you're being quoted — compounded, branded, or generic — since each bills differently. Lab testing, when required, is typically billed separately from membership as well. Patients researching Found should ask specifically which plan tier applies to their situation and what the full monthly total looks like before enrolling, rather than assuming a single advertised price applies universally.
Found's coaching and community features are a genuine differentiator for patients who want structured behavioral support alongside medication — habit tracking, an in-app community, and health-coach messaging are built into the core experience, not sold as an expensive add-on. Found also offers one of the broader medication toolkits in the space, including non-GLP-1 options for patients who aren't eligible for or don't want a GLP-1.
Where the Tradeoffs Are
Patient reviews have noted mixed experiences with cancellation processes and communication that happens primarily through in-app messaging rather than phone support. For cash-pay patients specifically, the combination of membership fees, medication costs, and separately-billed labs can add up to a less predictable total than a simpler flat-rate model.
Who Found Fits Best
- Want structured behavioral coaching and community support built in
- Value having both compounded and brand-name medication options under one platform
- Are comfortable navigating a multi-tier plan structure to find your best fit
- Want a single, easy-to-compare flat price for GLP-1 treatment
- Don't need built-in behavioral coaching or community features
- Prefer knowing your exact monthly cost without cross-referencing plan tiers
One plan.
One flat price.
Compounded semaglutide at $197/month or tirzepatide at $297/month — medical evaluation, provider visits, and shipping all included, no tiers to compare.
Get Started → Or start your free health assessmentFrequently Asked Questions
Found typically offers a compounded GLP-1 plan, a branded GLP-1 plan (billed separately via insurance or cash pay), and a non-GLP-1 generics plan, each with different billing structures.
Generally no. Lab testing, when required by your provider, is typically billed separately from the membership fee at a Quest or Labcorp location, or through an at-home kit.
Yes. Found works with board-certified clinicians trained in obesity medicine and offers both FDA-approved brand-name medications and compounded alternatives depending on eligibility.
Because Found segments its offering into multiple plan families with different billing structures (compounded, branded, generic), understanding your true total cost requires knowing which specific plan applies to your situation, rather than a single universal price.
Yes. Found offers options like metformin, bupropion-naltrexone, and other non-GLP-1 medications for patients who aren't eligible for or don't want a GLP-1 medication.
Yes, generally. Luma Health's single flat price ($197/month semaglutide, $297/month tirzepatide) doesn't require navigating multiple plan tiers to understand your total monthly cost.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. PubMed 33567185
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PubMed 35658024
- U.S. Food and Drug Administration. Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide). FDA.gov. 2025. FDA Drug Approvals Database
- U.S. Food and Drug Administration. Human Drug Compounding and the FD&C Act. FDA.gov. FDA.gov